An official website of the United States government Here's how you know

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Biologic License Application (BLA): 020772
Company: QOL MEDCL

This Former NDA Was Deemed To Be a BLA on March 23, 2020.

Products on BLA 020772

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
SUCRAID	SACROSIDASE	8,500 IU/ML	SOLUTION;ORAL	Prescription	None	No	No

Approval Date(s) and History, Letters, Labels, Reviews for BLA 020772

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
04/09/1998	ORIG-1	Approval		N/A; Orphan	Letter (PDF) Review	Label is not available on this site.	https://www.accessdata.fda.gov/drugsatfda_docs/appletter/1998/20772ap_ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/98/20772.html

Supplements

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
08/02/2024	SUPPL-31	Supplement	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/020772s031lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2024/020772Orig1s031ltr.pdf
07/24/2024	SUPPL-30	Supplement	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/020772s030lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2024/020772Orig1s030ltr.pdf
05/25/2022	SUPPL-27	Supplement	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020772Orig1s027Lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2022/020772Orig1s027ltr.pdf
09/21/2015	SUPPL-20	Supplement		Label is not available on this site.
02/16/2015	SUPPL-19	Supplement		Label is not available on this site.
12/02/2014	SUPPL-17	Supplement		Label is not available on this site.
11/07/2014	SUPPL-15	Supplement		Label is not available on this site.
05/28/2013	SUPPL-13	Supplement		Label is not available on this site.
12/09/2010	SUPPL-11	Supplement	Letter (PDF)	Label is not available on this site.	https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/020772s011ltr.pdf
06/15/2011	SUPPL-8	Supplement	Letter (PDF)	Label is not available on this site.	https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/020772s008ltr.pdf
11/20/2008	SUPPL-7	Supplement		Label is not available on this site.
11/20/2008	SUPPL-6	Supplement		Label is not available on this site.
11/20/2008	SUPPL-5	Supplement	Letter (PDF)	Label is not available on this site.	https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/020772s005ltr.pdf
02/20/2008	SUPPL-4	Supplement		Label is not available on this site.
11/03/2006	SUPPL-2	Supplement	Letter (PDF)	Label is not available on this site.	https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2006/020772s002ltr.pdf

Labels for BLA 020772

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
08/02/2024	SUPPL-31	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/020772s031lbl.pdf
07/24/2024	SUPPL-30	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/020772s030lbl.pdf
05/25/2022	SUPPL-27	Labeling-Container/Carton Labels	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020772Orig1s027Lbl.pdf

Top